News & Trends - MedTech & Diagnostics
A lifeline for diabetic patients amidst hospital overcrowding

Diagnostics & MedTech News: The next stage of the world-first virtual emergency department has been launched, aligning with the commitment to enhance care for diabetes patients and alleviate pressure on overwhelmed hospital wards.
Ambulance Victoria paramedics and first responders are now armed with Abbott’s ketone testing kits, enabling them to measure ketone levels in individuals with diabetes. This proactive approach aims to detect and prevent diabetic ketoacidosis (DKA), a serious and potentially life-threatening complication that arises when the body cannot produce sufficient insulin.
Currently, Australia experiences over 9,000 hospitalisations for DKA annually, making it the leading cause of admission for individuals with diabetes. By equipping paramedics with ketone testing kits, the aim is to assess the risk of diabetic ketoacidosis and determine which patients require hospital care versus those who can be safely managed at home, thus reducing unnecessary visits to emergency departments.
The Victorian Virtual Emergency Department (VVED) Diabetes offers free video consultations for individuals with diabetes facing urgent but non-life-threatening complications. Delivered by diabetes nurse practitioners and emergency clinicians, this service provides critical support to those residing in regional and remote areas where urgent care access is often limited.
Dr Ben Nash, an endocrinologist at Northern Health overseeing the latest addition to the VVED Diabetes service, stated, “Equipping paramedics with ketone testing is a gamechanger. Up until now, most cases of hyperglycaemia attended by paramedics are transported to a hospital. Ketone testing will allow for rapid identification and management of suspected diabetic ketoacidosis, while also identifying those that can be safely managed at home.”
Professor Elif Ekinci, an endocrinologist and Head of the Department of Medicine at the University of Melbourne, said “It was a dream of mine to get a service like this off the ground and to make a tangible difference to people living with diabetes by reducing complications and making care and support more accessible.”
The clinical operations of the diabetes VVED Diabetes are funded by the Victorian Government, complemented by research support from a $915,823 National Health and Medical Research Council (NHMRC) grant.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics

Landmark study exposes stark differences in ICD battery life and patient risk
A new independent study examining over 35,000 implantable cardioverter-defibrillators (ICDs) has uncovered significant differences in battery longevity across several medtech […]
MoreNews & Trends - Pharmaceuticals

Industry roundtable to shape Australia’s genomics policy
An invitation-only roundtable of key industry leaders and representatives from both federal and state governments is convening today to shape […]
MoreNews & Trends - MedTech & Diagnostics

Pathology indexation reboot leaves essential services behind
After nearly three decades of stagnation, the federal government has reinstated annual indexation for selected Medicare Benefits Schedule (MBS) pathology […]
MoreDigital & Innovation

Navigating telehealth’s crowded rulebook: New consortium adds its voice to the mix
A newly formed Consortium of telehealth providers and private health insurers has come together to develop national standards for the […]
More